Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer now shows Revision: v3.6.3, replacing the previous version, indicating a minor site update to the revision history.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of Revision: v3.6.0, indicating a software release version. This update reflects an infrastructure or UI deployment rather than changes to the study results or page content.SummaryDifference0.1%

- Check38 days agoChange DetectedThe recruitment status now reads 'No longer looking for participants', indicating enrollment for the study is closed. The page has also been updated to Revision: v3.6.0.SummaryDifference0.5%

- Check46 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous v3.5.4. This indicates a software release update and affects only the site’s version label in the page footer.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays a revised version tag, changing from v3.5.3 to v3.5.4. This is a metadata update indicating the page version and does not modify the study content or results presentation.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page’s displayed site revision/version number was updated from v3.5.2 to v3.5.3. This reflects a site release change rather than any update to the study’s results or details.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.